 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Treatment of Zollinger-Ellison Syndrome With Prevacid
|
|
|
|
Phase IV
|
|
|
|
F030107005
NCT00204373
|
|
| |
Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
|
|
|
|
Phase IV
|
|
|
|
hsc 031192
ind 70268, NCT00285272
|
|
| |
Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
|
|
|
|
Phase IV
|
|
|
|
R01 MH071580
DATR A3-NSS, NCT00352885
|
|
| |
A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer
|
|
|
|
Phase IV
|
|
|
|
A0081128
NCT00381095
|
|
| |
Pregabalin in Preventing and Treating Peripheral Neuropathy Caused by Chemotherapy in Patients Undergoing Chemotherapy for Advanced Colorectal Cancer
|
|
|
|
Phase IV
|
|
|
|
PFIZER-A0081124
RAH-060919, NCT00380874
|
|
| |
Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
|
|
|
|
Phase IV
|
|
|
|
RASALL
NCT00186940
|
|
| |
Effect of Eszopiclone on Sleep Disturbance & Pain in Cancer
|
|
|
|
Phase IV
|
|
|
|
UCSD 060340
ESRC 054, NCT00365261
|
|
| |
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
|
|
|
|
Phase IV
|
|
|
|
PRO06080002 (REBBeCA II)
NCT00485953
|
|
| |
Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
|
|
|
|
Phase IV
|
|
|
|
R01 MH079420
DAHBR 96-BHC, NCT00536172
|
|
| |
Learning Impairments Among Survivors of Childhood Cancer
|
|
|
|
Phase IV
|
|
|
|
MEMFX2
RO1-CA078957, UO1-CA81445, P30-CA2Z1765, NCT00576472
|
|
